Neurocrine Biosciences Inc., 10% Owner at Voyager Therapeutics, Inc. (VYGR), bought 8,359,456 shares at $11.96 ($100.0M) on 2019-03-12, disclosed to the SEC on 2019-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.96 | 4,179,728 | $50.0M | 50.0% |
| 2 | $11.96 | 4,179,728 | $50.0M | 50.0% |
| Total | $11.96 avg | 8,359,456 | $100.0M | 100% |